Prof David R. Liu, Professor at Harvard University, the Broad Institute, and HHMI was interviewed by the Sheeky Science Show. In the interview, they discussed how to make precise genome editing safe & efficient using the latest CRISPR tech advances in base editing and prime editing and taking it to the clinic (e.g Beam Therapeutics). They talked about the next frontier, epigenome editing. There are currently two major ways to deliver CRISPR gene therapies into the human body. There is the AAD virus and the LNP (lipid nanoparticle). There are hundreds of different AAD virus and lipid nanoparticles. Verve Therapeutics
The post Editing the Epigenome for Better Health and a Pathway to Antiaging first appeared on NextBigFuture.com.
Comments
Post a Comment